Rapid Fire : Tumor Lysis Syndrome - 22/07/18
Résumé |
Tumor lysis syndrome (TLS) is a life-threatening oncologic emergency, characterized by a constellation of hyperkalemia, hyperuricemia, hyperphosphatemia, and hypocalcemia. The spectrum ranges from patients who are asymptomatic to those who go into cardiac arrest and die. Prompt recognition and initiation of treatment by emergency physicians are key, especially in the early stages of the syndrome. This case-based review presents an overview of the key points in pathophysiology, diagnosis, and management of TLS that are key to emergency physicians.
Le texte complet de cet article est disponible en PDF.Keywords : Tumor lysis syndrome, Uric acid, Rasburicase, Metabolic emergency, Cancer, Emergency
Plan
Disclosure Statement: The author has no relationship with a commercial company that has a direct financial interest in the subject matter or materials discussed in the article or with a company making a competing product. |
Vol 36 - N° 3
P. 517-525 - août 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?